Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

Quantum computing and artificial intelligence (AI) can be combined with classical computing methods to design and discover small-molecule candidates that target the cancer-driving KRAS protein, ...

Siddhartha Mukherjee and Reid Hoffman’s Manas AI aims to help design and screen molecules that ... we can now help the world's best drug development scientists to augment and amplify their ...

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

AI, and cloud computing towards improving existing computational methods while exploring new algorithms to address a wide range of drug design challenges. “We look forward to helping expedite ...